Profile: Siegfried (USA), Inc. is a manufacturer of APIs and advanced pharmaceutical-related intermediates. Our product line includes acetylcholine chloride, amitriptyline hcl, amobarbitol sodium, ben.. Provide products various. Contact us now to get t
Siegfried Group will acquire the Hameln Pharma in Germany, consisting of Hameln Pharmaceuticals GmbH and Hameln RDS GmbH, with effect from end November 2014. Hameln Pharma is active in the development and production of sterile liquid pharmaceutical products for international pharma companies; the Siegfri...
Siegfried Holding AG Equities SFZN CH0014284498 Pharmaceuticals Market Closed - Swiss Exchange 11:31:50 2025-02-12 am EST 5-day change 1st Jan Change 1,054.00 CHF +0.19% 0.00% +6.90% Dec. 23 Swiss Stocks Gain; Economic Sentiment Downbeat MT Dec. 23 Siegfried Maintains Position ...